Clinical Trial Update: Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating cisplatin, cetuximab, and temsirolimus for recurrent or metastatic squamous cell carcinoma of the head and neck has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• CISPLATIN (cisplatin)
• ERBITUX (cetuximab)
• Torisel (Temsirolimus)

Snippet

Sponsor: University of Tennessee Cancer Institute | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1, Phase 2 | Status: TERMINATED